MyMD Pharmaceuticals Inc (MYMD)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
May 10, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
MyMD Pharmaceuticals Total Liabilities (Quarterly): 5.493M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.493M |
| September 30, 2023 | 5.716M |
| June 30, 2023 | 14.51M |
| March 31, 2023 | 15.31M |
| December 31, 2022 | 2.845M |
| September 30, 2022 | 1.904M |
| June 30, 2022 | 3.043M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.581M |
| December 31, 2021 | 1.166M |
| September 30, 2021 | 2.118M |
| June 30, 2021 | 3.374M |
| March 31, 2021 | 2.374M |
| December 31, 2020 | 5.934M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.166M
Minimum
Dec 2021
15.31M
Maximum
Mar 2023
5.105M
Average
3.043M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Acrivon Therapeutics Inc | 17.07M |
| Vincerx Pharma Inc | 6.995M |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.86M |
| Shareholders Equity (Quarterly) | 12.37M |